GENDER AFFIRMING CARE
AND MENTAL HEALTH OUTCOMES
Research consistently associates gender-affirming care with improved mental-health outcomes among transgender young people, including lower rates of depression and anxiety and better quality of life and psychosocial functioning. These findings show association rather than proof of cause, because the studies are largely observational. The elevated baseline risk they address is driven by stigma and mistreatment, not by being transgender. Major US medical organizations regard this care as evidence-based and medically necessary, while some evidence reviews note that the certainty of the long-term research is still limited. Low certainty in a body of research is a statement about study quality, not a finding that care is harmful.
The most important thread running through this research is that support helps. The factors linked to better mental health, acceptance, respect, and access to care, are the ones families and communities can offer. If your family is navigating this, that is genuinely encouraging, and the resources on our where to get help page are there whenever you need them.
Terminology and language note: You may see this care called gender-affirming care, transition-related care, or supportive care; this page mostly uses "supportive care," and the terms describe the same thing. Two points about the research itself: most studies measure mental-health symptoms through screening questionnaires rather than formal diagnoses, and most are observational, so they show that things move together, not that one is proven to cause the other.
CONTENT NOTE
This is information, not medical advice, and it explains a clinical scale rather than any individual's care. Whether and when any medication is appropriate for a particular young person is a decision for that young person, their family, and their qualified healthcare providers, and in nearly all cases minors cannot receive it without parental consent. If you are in immediate danger, call 911; for support any time, call or text 988.
-
The research points one way. Studies consistently link supportive care and acceptance to lower depression and anxiety and better quality of life among trans youth.
-
These are associations. The studies show that support and better outcomes move together, not that one is proven to cause the other.
-
Youth and adult evidence differ. The strongest youth-specific data come from US cohort studies; some large reviews draw mostly on adults.
-
Risk is stigma-driven. The elevated baseline risk reflects rejection and discrimination, not being transgender.
-
Consensus and caution coexist. Major US medical bodies regard the care as evidence-based, while some reviews find the long-term evidence has low certainty, which is not evidence of harm.
KEY TAKEAWAYS
WHAT OUTCOMES THE RESEARCH LOOKS AT
Studies of mental-health outcomes track several distinct measures, and it helps to see them laid out before looking at the findings.
Sources: JAMA Network Open (2022); Journal of the Endocrine Society (2021); New England Journal of Medicine (2023).
DEPRESSION AND ANXIETY
Research associates supportive care with lower rates of depression and anxiety, with the clearest youth-specific data coming from US studies. A prospective study of 104 transgender and nonbinary youth ages 13 to 20 in JAMA Network Open found that, over 12 months, receiving care including puberty-pausing medication and gender-affirming hormones was associated with 60% lower odds of moderate or severe depression. The study measured symptoms through screening questionnaires, had no control group, and its authors described care as associated with, not proven to cause, these outcomes.
Larger systematic reviews point the same way, though they draw mostly on adults. A review in the Journal of the Endocrine Society found that hormone therapy may be associated with improved quality of life and decreased depression and anxiety, while noting that its evidence base was predominantly adult, with only three of its twenty studies focused on youth. A 2023 review in Nature Human Behaviour similarly suggested reductions in psychological distress and depressive symptoms, again drawn largely from adult studies. These reviews are useful for the overall direction of the evidence, but their adult focus means they should not be read as youth-specific findings. For the treatment itself, see hormone therapy for trans youth.
QUALITY OF LIFE AND PSYCHOSOCIAL FUNCTIONING
The strongest longitudinal youth data associate gender-affirming care with improvements in quality of life and psychosocial functioning.
A US study of 315 young people ages 12 to 20 across four sites, published in the New England Journal of Medicine, found improvements in psychosocial functioning and life satisfaction, along with decreases in depression and anxiety symptoms, across two years of gender-affirming hormone treatment.
Because every participant received care, this reflects change within the group over time rather than a comparison against untreated peers, which is a genuine limitation the authors themselves note.
It remains, at present, among the strongest prospective US youth data available.
SUICIDE RISK
Suicide risk is one mental-health outcome among several, and because it requires especially careful and precise treatment, we cover it in depth on its own page. In brief, research consistently links supportive care and acceptance to lower rates of suicidal thoughts, and family acceptance to lower rates of suicide attempts, as associations rather than proof of cause. For the full, carefully sourced picture, including the important distinction between suicidal thoughts, attempts, and deaths, see Does gender-affirming care reduce suicide risk?
WHY BASELINE MENTAL-HEALTH RISK IS ELEVATED
The higher baseline rates of depression and anxiety among transgender young people are understood by researchers to be driven by stigma, rejection, and discrimination, not by being transgender. For context on the size of that gap, a 2024 study in the Journal of Adolescent Health found that transgender and nonbinary adolescents reported chronic sadness or hopelessness at much higher rates than their cisgender, heterosexual peers (74% versus 35%).
Framing this as a response to how young people are treated, rather than as something inherent to being transgender, is both what the evidence supports and the responsible way to read it. It also explains why acceptance and support show up so consistently as protective.
For the fuller mental-health picture, see transgender youth mental health statistics and depression and anxiety in trans youth.
WHY THESE FINDINGS ARE ASSOCIATIONS, NOT PROOF
Most of this research is observational, so it can show that supportive care and better mental health go together without proving that one causes the other. Studies follow groups over time or compare groups, and much of the outcome data comes from screening questionnaires rather than formal diagnoses, which is normal in this field but worth naming. That is why careful researchers, and this page, use "associated with" and "linked to" rather than "causes." The counterweight is consistency: the same direction shows up across different studies, populations, and outcomes, which is part of why medical organizations weigh the evidence as they do.
Consistency across many studies is not proof, but it is a meaningful pattern.
WHAT EVIDENCE REVIEWS SAY ABOUT CERTAINTY
Some independent reviews have concluded that the certainty of the long-term evidence is low, a finding about study quality rather than a finding that the care is harmful. Reviews including England's Cass Review and a 2025 report from the U.S. Department of Health and Human Services rated the certainty of parts of the evidence base as low, largely because much of it is observational rather than from randomized controlled trials. Low certainty describes gaps and limitations in the research, and it is not the same as evidence of harm.
There is also genuine debate about how to weigh this kind of evidence. Some researchers argue in a methodological commentary in the International Journal of Transgender Health that the absence of randomized trials does not mean the interventions are insufficiently supported, and that well-designed observational studies can appropriately guide care. That is an argument advanced by those authors, sitting alongside the reviews that call for more and better long-term data. Reasonable experts weigh the same limited evidence differently.
WHERE THE MEDICAL CONSENSUS LANDS
The major US medical and mental-health organizations regard this care as evidence-based and medically necessary. The American Medical Association, American Academy of Pediatrics, American Psychological Association, and Endocrine Society regard this care as evidence-based and medically necessary, weighing both the available research and the risks of withholding care. Aware of the evidence limitations, these bodies continue to support access, which is the strongest counterweight to the certainty critiques.